Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:04 AM
Ignite Modification Date:
2025-12-25 @ 5:04 AM
NCT ID:
NCT06012318
Eligibility Criteria:
Inclusion Criteria:
* Pathologically confirmed resectable, locally advanced, advanced metastatic esophageal cancer
* Having received or undergoing an immunotherapy-based treatment regimen
* Age 18-75 years
* ECOG PS of 0-2
* Adequate organ function
* Life expectancy \> 6 months
* Participants are fully informed about the whole study and are willing to sign the informed consent
Exclusion Criteria:
* Absence of immunotherapy regimen, or recieving radiotherapy.
* Presence of primary tumours elsewhere, such as gastric cancer, lung cancer or cervical cancer
* Severe organ function deterioration and intolerance to immunotherapy
* Pregnant or breast-feeding women
* Previous autoimmune disease
* Any other conditions that may affect patients' safety and compliance
* Psychological, family, social and other factors leading to inability to inform consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT06012318
Study Brief:
Protocol Section:
NCT06012318